Appreciate the post bones. I've never got in a disagreement with you, but your tone has been a bit on the bleak side. As you say, it looks better today than at anytime since pre fda approval. A deepend relationship with illumina would certainly accelerate adoption and revenues. |
Bones and his alter ego havingthelast...Has been deramping this since 7.5p bid.Bitter, angry and sad. I love the fact bones will be with us as we rise. The rise will drive him insane. Just hope his partner and kids don't get the full brunt if his frustration |
7.25 was the bottom but you were urging everyone to sell at 7.5 to help your short |
 OK let's keep a bit of perspective, guys.
Over the years bones698 and I have had several run-ins, and it's only by the thinnest of threads that I have never filtered him (as I have many others). He totally fails to realise, it seems, that he has brought all that hostility entirely on himself: not so much because of his views as such, unpalatable as many find them, but because of his sneering, arrogant, holier-than thou attitude and language and his contempt for those with whom he disagrees.
Nonetheless I have to admit that he has historically been right more often than wrong, so I fear we have to give him that.
And I think technically he is also correct in saying that a cash runway into early 2026 may not in itself be long enough to avoid a fundraising by probably June/July 25, unless the company is willing to risk a going concern qualification - generally considered a "black mark" - when the 2024 results are announced. (The 2023 results were announced on 2 June 2024).
It's always possible that there will be some sort of last-minute rescue - such as, perhaps, a deal with the likes of AZ or Illumina involving let's say £10m of upfront cash? but we've been waiting a long time for that, and there's no doubt that time is running out.....
Disclosure: I have no aliases and no connection with any other poster; have built up my family holdings in AGL bit by bit over the last 10 years, often (not always) at the wrong prices; have not sold a single share during that period, and have no intention of doing so at these levels; and currently speak for over 1m shares.
Bones, the message is clear: be politer and friendlier to your fellow posters and you might get a politer response and - who knows - maybe even some constructive and intelligent debate. Meanwhile could I enter a heartfelt plea: can both sides of the argument please drop the constant slagging-off, it's exceedingly tiresome and utterly spoils what would otherwise be a good board with some intelligent posters. @sicilian_kan I wonder whether you might feel able to be more proactive? |
Chart progression is great. Very constructive pattern.
free stock charts from uk.advfn.com
free stock charts from uk.advfn.com |
I think this will be over 35p very soon. Looking forward to Feb 6th presentation. |
i must be a sucker just added on this news breakeven now only 35p!
lets hope |
Andrew already saying that it's available to illumina customers |
Divvy darmz filtered after reading the first two of his 20 posts
Can't see bones but I can see he's been desperately trying to talk the company down
I'd advise closing those shorts of yours bones
You've watched it rise 50% from 10p and 100% from 7.5p
You're about to witness a huge stampede to buy shares when the next contract is announced
sent from my iPhone |
Have you got nothing better to do with your life than sit on ADVFN and type paragraphs of rubbish about a company you don't hold shares in?
It's truly pathetic to read.
AGL are making strides forward, the next RNS could easily be a formal partnership with Illumina which includes them taking an equity stake in AGL. If you said to me this time last year that SpaceX would invest in FTC and shares would be up 400% I'd have never believed it. The same thing could happen here. |
We were told not only a week ago the cash position and funded until 2026 |
Given that last year's placing was at 15p, and subcribers then saw their investment almost halve in a matter of months,it was always likely that a recovery to 15p would provoke some selling. But once these frustrated placees are out then we should enjoy a good run up into the 20's. |
The Scientific community will take note once they present, which is a week away. |
Trading has been pretty strange here today. There appears to be no interest in selling below 15p, yet as soon as the share price gets to 15.5p sellers jump in and stop the price rising further. Certainty curious to have churned nearly 11m shares and be flat versus the opening trades of the day. |
Why is it funny Bones?Answer that and don't hide behind a keyboard with an answer. Answer as a real person. Why is it funny?And what point do you get from talking down a share that's doubled since you've talked it down?Reevaluate yourself |
Jelenka and goosed, both very good points. |
waterloo01 - I suspect there's been a bit of conversation about the FDA 510 route to approval for other indications. Much quicker & much less costly. |
Let's get it embedded with their customer before we even mention FDA. BTW most likely Illumina's customers run from certified labs so FDA not required. They can do what they want in their own certified lab. |
Further, not just one cancer but multiple cancers. Now together might AGL and Illumina approach the FDA for a wide use label?
"ANGLE has already reported (RNS announcement dated 4 January 2024) on the successful development of a workflow for the dual analysis of CTC-DNA and ctDNA using the Illumina platform with a third-party assay kit (now under option for exclusive licence by ANGLE). In the forty-seven-patient study across four cancer types (breast, lung, ovarian and prostate), a significant number of patients had clinically relevant mutations found in their CTCs that were not present in ctDNA from the same blood draw. This data further validates these findings." |
Lmao. Still waiting for afternoon rocket here guys ,what happened ? Oh wait the market knows a fund raise is likely very soon and that today's news is likely to take years before it makes any money for agl . Funny watching the desperate rampathon from long term suffering holders desperate to claw back years of losses here . |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
